Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
OtherMinireview

Interplay between Non-coding RNAs and NRF2 in Different Cancers: Spotlight on miRNAs and Long non-coding RNAs

İlhan Yaylim, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso
Journal of Pharmacology and Experimental Therapeutics June 6, 2022, JPET-MR-2021-000921; DOI: https://doi.org/10.1124/jpet.121.000921
İlhan Yaylim
1Molecular Medicine, Istanbul University Aziz Sancar Institıte of Experimental Medicine, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: iyaylim@istanbul.edu.tr
Ammad Ahmad Farooqi
2Department of Molecular Oncology, Institute of Biomedical and Genetic Engineering (IBGE), Pakistan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ammad Ahmad Farooqi
Pelin Telkoparan-Akillilar
3Department of Medical Biology, Faculty of Medicine, Yuksek Ihtisas University, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luciano Saso
4Department of Physiology and Pharmacology, Sapienza University of Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Cancer is a multifactorial disease and a wealth of information has enabled us to develop a better understanding of the heterogeneous nature of cancer. Deregulation of spatio-temporally controlled signaling cascades played a central role in cancer progression. NRF2-driven signaling has attracted significant attention because of its ability to dualistically regulate cancer progression. Context-dependent diametrically opposed roles of NRF2-induced signaling are exciting. More importantly, non-coding RNA (ncRNA) mediated regulation of NRF2 and interplay between NRF2 and ncRNAs have added new layers of complexity to already intricate nature of NRF2 signaling. There is a gradual enrichment in the existing pool of knowledge related to interplay between microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) in different cancers. However, surprisingly, there are no clues about interplay between circular RNAs and NRF2 in various cancers. Future studies must converge on the identification of additional important lncRNAs and circular RNAs, which regulated NRF2-driven signaling or conversely NRF2 transcriptionally controlled their expression to regulate various stages of cancer.

Significance Statement Recently, many researchers have focused on the NRF2-driven signaling in cancer progression. Some possible strong interactions between NRF2-driven signaling and non-coding RNAs are still not clear. Future studies must be designed on critical molecules which take place NRF2-driven signaling and their expression to regulate various stages of cancer.

  • cancer
  • miRNA
  • Nrf2
  • Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics
Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 384 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 384, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interplay between Non-coding RNAs and NRF2 in Different Cancers: Spotlight on miRNAs and Long non-coding RNAs
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherMinireview

Non-coding RNAs and NRF2 in Different Cancers

İlhan Yaylim, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso
Journal of Pharmacology and Experimental Therapeutics June 6, 2022, JPET-MR-2021-000921; DOI: https://doi.org/10.1124/jpet.121.000921

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherMinireview

Non-coding RNAs and NRF2 in Different Cancers

İlhan Yaylim, Ammad Ahmad Farooqi, Pelin Telkoparan-Akillilar and Luciano Saso
Journal of Pharmacology and Experimental Therapeutics June 6, 2022, JPET-MR-2021-000921; DOI: https://doi.org/10.1124/jpet.121.000921
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Traumatic Brain Injury Pharmacology Trials
  • Generic Substitution of Antiseizure Medications
  • Potential Therapeutic Approaches to Nociplastic Pain
Show more Minireview

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics